drugset / Trial / NCT06016972
Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Qlaris' Phase 2 clinical trial investigating the safety, tolerability, and ocular hypotensive efficacy of QLS-111 in primary open-angle glaucoma (POAG) or ocular hypertension patients.
Timeline
- Start
- 2024-03-05
- Primary completion
- 2024-08-20
- Completion
- 2024-08-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QLS-111 | Unknown | 0.015 % | Other |
| Subject | QLS-111 | Unknown | 0.03 % | Other |
| Subject | QLS-111 | Unknown | 0.075 % | Other |